rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Status:
Unknown status
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Evaluation of efficacy and safety of recombinant factor VIIa versus standard therapy in
preventing early haematoma growth in spontaneous acute intracerebral haemorrhage in patients
treated with oral anticoagulants or antiplatelets agents